Warfarin Dose Adjustment for Subtherapeutic INR
For a patient on warfarin 2.5 mg daily with an INR of 1.75 (target 2.0-3.0), continue the current dose without adjustment and recheck INR in 1-2 weeks. 1
Rationale for No Dose Change
The INR of 1.75 is only 0.25 units below the therapeutic range, which falls well within the guideline threshold for maintaining the current dose:
The American College of Chest Physicians recommends continuing the current warfarin dose for a single INR reading ≤0.5 below the therapeutic range in patients with previously stable INRs 1
Evidence from 3,961 patients demonstrates that warfarin doses do not require adjustment for INRs between 1.7 and 3.3, as immediate dose changes for minor deviations do not improve outcomes compared to maintaining the current dose 1, 2
Optimal warfarin management involves changing doses only when INR falls to 1.7 or lower, not at 1.75 2
Follow-Up Monitoring
Recheck INR in 1-2 weeks to ensure the value is not progressively declining 1
Once stable therapeutic INR is achieved, monitoring intervals can be extended up to 12 weeks 1
Critical Factors to Investigate Before Any Dose Change
Before considering dose adjustment at future visits, evaluate:
Medication adherence - confirm the patient is taking warfarin consistently 1
Dietary vitamin K intake - assess for recent changes in green leafy vegetable consumption 1
Intercurrent illness - diarrhea or vomiting may decrease warfarin absorption 1
New medications - many drugs interact with warfarin metabolism 3
When Dose Adjustment IS Warranted
If subsequent INR readings show:
INR persistently ≤1.7 on repeat testing - then consider dose increase 2
Multiple subtherapeutic readings - more aggressive adjustment may be needed 1
High-risk conditions (mechanical heart valves) with persistently low INR - warrant more aggressive management 1
Dose Adjustment Principles (For Future Reference)
When dose changes are actually needed:
Most changes should alter the total weekly dose by 5-20% 4
For a patient on 2.5 mg daily (17.5 mg weekly), a 10% increase would be approximately 1.75 mg weekly (add 0.25 mg on one day per week) 4
Avoid loading doses or large adjustments that can cause excessive INR elevation 3, 4
Common Pitfalls to Avoid
Do not overreact to a single slightly subtherapeutic INR - this does not improve outcomes and increases INR instability 1, 2
Do not initiate heparin bridging for a single subtherapeutic INR - this increases bleeding risk without clear benefit, even in high-risk patients 1
Avoid frequent dose changes in response to minor INR fluctuations - patients with fewer dose changes achieve better INR control (mean TTR 70.1% vs 62.0%) 2